Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
about
Biomarker-based diagnosis of pacemaker and implantable cardioverter defibrillator pocket infections: A prospective, multicentre, case-control evaluation.Antibiotic Utilization and Opportunities for Stewardship Among Hospitalized Patients With Influenza Respiratory Tract Infection.Effect of Vitamin D Supplementation on Procalcitonin as Prognostic Biomarker in Patients with Ventilator Associated Pneumonia Complicated with Vitamin D Deficiency.Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia.
P2860
Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
description
2014 nî lūn-bûn
@nan
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Procalcitonin, a valuable biom ...... community-acquired pneumonia.
@en
Procalcitonin, a valuable biom ...... community-acquired pneumonia.
@nl
type
label
Procalcitonin, a valuable biom ...... community-acquired pneumonia.
@en
Procalcitonin, a valuable biom ...... community-acquired pneumonia.
@nl
prefLabel
Procalcitonin, a valuable biom ...... community-acquired pneumonia.
@en
Procalcitonin, a valuable biom ...... community-acquired pneumonia.
@nl
P2860
P356
P1476
Procalcitonin, a valuable biom ...... community-acquired pneumonia.
@en
P2093
E K C Wong
S T Lindstrom
P2860
P304
P356
10.1111/IMJ.12374
P577
2014-04-01T00:00:00Z